Literature DB >> 19887450

Distinctive properties of the hyaluronan-binding domain in the lymphatic endothelial receptor Lyve-1 and their implications for receptor function.

Suneale Banerji1, Branwen R S Hide, John R James, Martin E M Noble, David G Jackson.   

Abstract

The lymphatic endothelial hyaluronan (HA) receptor Lyve-1 is a member of the Link protein superfamily most similar to the leukocyte HA receptor CD44. However, the structure of Lyve-1 and the nature of its interaction with ligand are obscure. Here we present new evidence that Lyve-1 is functionally distinct from CD44. Using truncation mutagenesis we confirm that Lyve-1 in common with CD44 contains an extended HA-binding unit, comprising elements flanking the N and C termini of the consensus lectin-like Link module, bridged by a third conserved disulfide linkage that is critical for HA binding. In addition, we identify six essential residues Tyr-87, Ile-97, Arg-99, Asn-103, Lys-105, and Lys-108 that define a compact HA-binding surface on Lyve-1, encompassing the epitope for an adhesion-blocking monoclonal antibody 3A, in an analogous position to the HA-binding surface in CD44. The overtly electrostatic character of HA binding in Lyve-1 and its sensitivity to ionic strength (IC(50) of 150 mm NaCl) contrast markedly with CD44 (IC(50) > 2 m NaCl) in which HA binding is mediated by hydrogen bonding and hydrophobic interactions. In addition, unlike the extended Link module in CD44, which binds HA efficiently when expressed as a soluble monomer (K(d) = 65.7 mum), that of Lyve-1 requires artificial dimerization, although the full ectodomain is active as a monomer (K(d) = 35.6 mum). Finally, full-length Lyve-1 did not form stable dimers in binding-competent 293T transfectants when assessed using bioluminescent resonance energy transfer. These results reveal that elements additional to the extended Link module are required to stabilize HA binding in Lyve-1 and indicate important structural and functional differences with CD44.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19887450      PMCID: PMC2856280          DOI: 10.1074/jbc.M109.047647

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Mononuclear leukocytes preferentially bind via CD44 to hyaluronan on human intestinal mucosal smooth muscle cells after virus infection or treatment with poly(I.C).

Authors:  C A de La Motte; V C Hascall; A Calabro; B Yen-Lieberman; S A Strong
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

2.  Cutting edge: an inducible sialidase regulates the hyaluronic acid binding ability of CD44-bearing human monocytes.

Authors:  S Katoh; T Miyagi; H Taniguchi; Y Matsubara; J Kadota; A Tominaga; P W Kincade; S Matsukura; S Kohno
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

Review 3.  The lymphatics revisited: new perspectives from the hyaluronan receptor LYVE-1.

Authors:  David G Jackson
Journal:  Trends Cardiovasc Med       Date:  2003-01       Impact factor: 6.677

4.  Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding.

Authors:  N M English; J F Lesley; R Hyman
Journal:  Cancer Res       Date:  1998-08-15       Impact factor: 12.701

5.  Characterization of a functional hyaluronan-binding domain from the human CD44 molecule expressed in Escherichia coli.

Authors:  S Banerji; A J Day; J D Kahmann; D G Jackson
Journal:  Protein Expr Purif       Date:  1998-12       Impact factor: 1.650

6.  Mechanism of ligand binding to E- and P-selectin analyzed using selectin/mannose-binding protein chimeras.

Authors:  D Torgersen; N P Mullin; K Drickamer
Journal:  J Biol Chem       Date:  1998-03-13       Impact factor: 5.157

7.  Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion.

Authors:  M Mohamadzadeh; H DeGrendele; H Arizpe; P Estess; M Siegelman
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

Review 8.  Activation and interaction of CD44 and hyaluronan in immunological systems.

Authors:  M H Siegelman; H C DeGrendele; P Estess
Journal:  J Leukoc Biol       Date:  1999-08       Impact factor: 4.962

9.  LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan.

Authors:  S Banerji; J Ni; S X Wang; S Clasper; J Su; R Tammi; M Jones; D G Jackson
Journal:  J Cell Biol       Date:  1999-02-22       Impact factor: 10.539

10.  Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity.

Authors:  J Sleeman; W Rudy; M Hofmann; J Moll; P Herrlich; H Ponta
Journal:  J Cell Biol       Date:  1996-11       Impact factor: 10.539

View more
  23 in total

Review 1.  Hyaluronan biology: A complex balancing act of structure, function, location and context.

Authors:  Stavros Garantziotis; Rashmin C Savani
Journal:  Matrix Biol       Date:  2019-02-23       Impact factor: 11.583

2.  Development of the LYVE-1 gene with an acidic-amino-acid-rich (AAAR) domain in evolution is associated with acquisition of lymph nodes and efficient adaptive immunity.

Authors:  Shuan Shian Huang; Ya-Wen Li; Jen-Leih Wu; Frank E Johnson; Jung San Huang
Journal:  J Cell Physiol       Date:  2017-10-04       Impact factor: 6.384

3.  What is special about 200 kDa hyaluronan that activates hyaluronan receptor signaling?

Authors:  Paul H Weigel; Bruce A Baggenstoss
Journal:  Glycobiology       Date:  2017-09-01       Impact factor: 4.313

4.  Unbinding of hyaluronan accelerates the enzymatic activity of bee hyaluronidase.

Authors:  Attila Iliás; Károly Liliom; Brigitte Greiderer-Kleinlercher; Stephan Reitinger; Günter Lepperdinger
Journal:  J Biol Chem       Date:  2011-08-12       Impact factor: 5.157

Review 5.  An alternative view of the proposed alternative activities of hemopexin.

Authors:  Marcia R Mauk; Ann Smith; A Grant Mauk
Journal:  Protein Sci       Date:  2011-03-30       Impact factor: 6.725

6.  Analysis of CD44-hyaluronan interactions in an artificial membrane system: insights into the distinct binding properties of high and low molecular weight hyaluronan.

Authors:  Patricia M Wolny; Suneale Banerji; Céline Gounou; Alain R Brisson; Anthony J Day; David G Jackson; Ralf P Richter
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

7.  Characterization of cells expressing lymphatic marker LYVE-1 in macaque large intestine during simian immunodeficiency virus infection identifies a large population of nonvascular LYVE-1(+)/DC-SIGN(+) cells.

Authors:  Yang-Kyu Choi; Beth A Fallert Junecko; Cynthia R Klamar; Todd A Reinhart
Journal:  Lymphat Res Biol       Date:  2013-03       Impact factor: 2.589

8.  Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1.

Authors:  Louise A Johnson; Suneale Banerji; William Lawrance; Uzi Gileadi; Gennaro Prota; Kayla A Holder; Yaowaluck M Roshorm; Tomáš Hanke; Vincenzo Cerundolo; Nicholas W Gale; David G Jackson
Journal:  Nat Immunol       Date:  2017-05-15       Impact factor: 25.606

9.  The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering.

Authors:  Cuixia Yang; Manlin Cao; Hua Liu; Yiqing He; Jing Xu; Yan Du; Yiwen Liu; Wenjuan Wang; Lian Cui; Jiajie Hu; Feng Gao
Journal:  J Biol Chem       Date:  2012-11-01       Impact factor: 5.157

10.  The interaction between LYVE-1 with hyaluronan on the cell surface may play a role in the diversity of adhesion to cancer cells.

Authors:  Yan Du; Hua Liu; Yiqing He; Yiwen Liu; Cuixia Yang; Muqing Zhou; Wenjuan Wang; Lian Cui; Jiajie Hu; Feng Gao
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.